Public Health | May 07, 2026
Experts urge govt. to make 2 mg and 4 mg nicotine replacement therapies more accessible
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
Once finalized, cough syrups will no longer be available for over-the-counter sale
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
The company sees the business reaching $100mn
Subscribe To Our Newsletter & Stay Updated
